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OPINION ARTICLE
 Cancer quasispecies and stem-like adaptive aneuploidy [v1; ref
status: indexed, http://f1000r.es/29s]
Domenico Napoletani , Michele Signore , Daniele C Struppa1 2 3
Institute for Quantum Studies, Chapman University, Orange, CA, 92866, USA1
Department of Hematology, Oncology and Molecular Medicine, Tumor Stem Cell Biobank, Istituto Superiore di Sanita, 00161, Rome, Italy2
Schmid College of Science and Technology, Chapman University Chapman University, Orange, CA, 92866, USA3
Abstract
In this paper we develop a theoretical frame to understand self-regulation of
aneuploidy rate in cancer and stem cells. This is accomplished building upon
quasispecies theory, by leaving its formal mathematical structure intact, but by
drastically changing the meaning of its objects. In particular, we propose a
novel definition of chromosomal master sequence, as a sequence of physically
distinct whole or fragmented chromosomes, whose length is taken to be the
sum of the copy numbers of each whole or fragmented chromosome. This
fundamental change in the functional objects of quasispecies theory allows us
to show that previously measured aneuploidy rates in cancer populations are
already close to a formally derived aneuploid error threshold, and that any
value of aneuploidy rate larger than the aneuploid error threshold would lead to
a loss of fitness of a tumor population. Finally, we make a phenomenological
analysis of existing experimental evidence to argue that single clone cancer
cells, derived from an aneuploid cancer subpopulation, are capable of
self-regulating their aneuploidy rate and of adapting it to distinct environments,
namely primary and metastatic microenvironments. We also discuss the
potential origin of this self-regulatory ability in the wider context of
developmental and comparative biology and we hypothesize the existence of a
diversification factor, i.e. a cellular mechanism that regulates adaptation of
aneuploidy rates, active in all embryo, adult and cancer stem cells.
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Introduction
In normal cells the number of chromosomes and the total DNA 
content depends on the phase of the cell cycle1. Non-diploid chro-
mosome content, also known as aneuploidy, is instead the most com-
mon feature of human tumor cells2–4. This feature of tumor cells 
is commonly associated with acquired resistance to various kinds 
of treatments such as radio- or chemotherapy2–5. Nonetheless, it is 
not completely clear whether aneuploidy per se contributes to and 
drives tumor development, or if instead it is deleterious. In fact, 
individuals carrying an extra copy of chromosome 21 have a 50% 
lower probability of developing solid tumors than do individuals 
with the correct chromosome number6,7 and although aneuploidy is 
compatible with organism and cell viability, the presence of addi-
tional copies of chromosomes decreases the overall cellular fitness8. 
What is clear is that chromosomal instability, i.e. the tendency to 
gain or lose parts of the genome during cell replication, seems to 
give an advantage to tumor cells9, and clonal heterogeneity within 
tumors is one of the main causes of tumor dormancy and resistance 
to anti-cancer therapies5,10. Indeed, it has been demonstrated that 
even a small population of cells derived from a single cancer cell 
clone (diversified population from a single cell), could be responsi-
ble for drug resistance and, upon removal of the drug, the popula-
tion spontaneously reverted to a sensitive state11,12.
The development of single-cell sequencing techniques13 has recent-
ly allowed a wide range of studies analyzing chromosomal vari-
ability in primary and metastatic tumor cells, as well as healthy 
tissues14,15. In particular in Navin et al.16 it is shown that metastatic 
tumors are likely to be the product of single clones proliferating 
from the primary tumor by observing the microvariation of the inte-
ger copy number of consensus sequences in individual tumor cells 
through single-cell sequencing.
In this paper we are concerned with measurable changes in the 
aneuploid heterogeneity of populations, due to different levels of 
chromosomal instability, and to emphasize even more the close link 
between aneuploidy and chromosomal instability. We will refer 
to the latter as aneuploidy rate, formally defining aneuploidy rate 
as the average probability that there is at least one new aneuploid 
modification per chromosome during cell replication. We will dem-
onstrate in the Discussion that simple and verifiable statistical con-
sequences of the findings of Navin et al.16 are logically bound to 
imply the following proposition.
Adaptive Aneuploidy in Cancer Cells: Single clone cancer cells 
derived from an aneuploid cancer subpopulation are capable 
of adapting their aneuploidy rate and display distinct aneuploid 
rates in distinct environments, namely primary and metastatic 
microenvironments.
The full impact of this proposition hinges on the potential ability 
to harness adaptive aneuploidy and potentially alter the aneuploidy 
rate of cancer cells. The theoretical frame for such a program can 
be built on quasispecies theory, a general evolutionary model for 
error-prone self replicative systems17, first introduced by Eigen18. 
The potential relevance of quasispecies theory to cancer biology 
has already been suggested19,20 but unlike previous attempts20–26, 
we do not recommend in this paper alternative, structurally diffnt 
quasispecies models of cancer cell subpopulations dynamics. 
Instead, after a quick review of the relevant elements of standard 
quasispecies theory, we note the limits of this theory for the study 
of eucaryotic cells, and show that only by defining a novel notion 
of chromosomal master sequence it is possible to radically shift 
the whole standard quasispecies theory to a new categorical con-
text (i.e. the scenario of cell populations with variable aneuploidy 
rates) and properly justify a valid aneuploid quasispecies theory. 
This new context allows us to predict (similarly to what the stand-
ard quasispecies theory does for single base error rates) a maximal 
aneuploidy rate, an error threshold, after which each cancer sub-
population loses its identity, and therefore its ability to pass on its 
selectively advantageous genetic traits to future cell generations, 
which is referred to as error catastrophe27.
Finally, in the Discussion we perform a phenomenological analysis 
of some especially illuminating single cell analysis experiments, 
from Navin et al.16, that seem to support our proposition on the 
existence of adaptive aneuploidy in cancer cells. We then speculate on 
the possible biological basis of self-regulation of aneuploidy rates 
in cancer cells. Such refined ability is unlikely to be the product of 
a single, specific tumor evolutionary history, rather, we will argue 
that embryo and adult stem cells already display very finely regu-
lated rates of aneuploidy, suggesting that a common cellular mecha-
nism of adaptation of aneuploidy is at play, a diversification factor, 
which is possibly reactivated in cancer stem cells.
Aneuploid quasispecies
The quasispecies framework
As noted in the Introduction, we need to redefine the main quanti-
ties at play in quasispecies theory to make it an appropriate ground 
for the biology of aneuploidy, and we begin by briefly sketching the 
argument that leads to the error threshold inequality.
The concept of quasispecies was first introduced by Eigen18,28, and 
it is a powerful way to relate the structure of population dynamics 
to the error rate of single base replication in viruses or unicellular 
organisms27,29. The most important consequence of the theory is that 
it is possible to determine theoretically a threshold on the error rate 
such that, if the error rate of replication of genomic sequences is 
pushed above the threshold, the subpopulation will not be able to 
retain its identity, for a wide range of models for fitness distribution 
in the population (cf. Schuster30, page 81).
Assuming there are N subpopulation types within a population, we 
start by writing down the differential equation that describes the 
rate of change dx
m
 of type m in terms of the instantaneous size xk(t), 
k = 1, ..., N of all types:
        
 
(1)
W
mm
 is the rate of effective excess production of sub-population type 
m, and if we consider the genetic sequence associated to type m, we 
can write W
mm
 = Q
mmAm − Dm, with Qmm the probability of precise 
reproduction of sequence m, A
m
 the growth rate of type m, and D
m
 
its mortality rate. Ē(t) = Σk Ek xk is the average, over all types, of the 
dx
dt
W E t x t W x tm mm m mk k
k m
= − +
≠
∑( ( )) ( ) ( ),
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fact, together with very low single nucleotide errors for humans, 
implies that the fitness of mutants of an hypothetical master 
sequence does not change significantly, and the fitness distribution 
of mutants around the master sequence is likely to decay linearly, or 
sub-linearly, a scenario under which no error threshold is possible30.
Indeed, the existence of Lynch syndrome or hereditary non- 
polyposis colorectal carcinomas (HNPCC), which are characterized 
by a higher risk of colon cancer, show the inability of the basic qua-
sispecies theory to predict the maximum single nucleotide error that 
is viable for a tumor. HNPCC tumors, as well as all microsatellite 
instable (MSI) colon cancers, arise because of a break down of the 
mismatch repair mechanism32,33. Therefore, MSI cancer cells dis-
play increased error rates of single nucleotide replication by 1 to 3 
orders of magnitude, with respect to the baseline single nucleotide 
error rate 1 − q¯ in healthy cells, estimated to range between 10−9 
and 10−10 for the human genome (see Alberts et al.34, page 271, and 
Gundry & Vijg35, Lange et al.36 and Jiricny37).
Now recall that the human genome has roughly 3.2 × 109 nucleo-
tides (see Alberts et al.34, page 206), and note that for organisms 
with very large genomes, the relative superiority σ¯
m
 of a master 
sequence associated to a given subpopulation cannot be very large 
(vis a vis other subpopulations), as any given mutation will only 
affect its fitness marginally27, and therefore σ¯ 
m
 ≈ 1. Given these 
numerical estimates, according to the error threshold inequality in 
Equation 3, MSI tumors would fail to satisfy the error threshold 
inequality to such an extent that they should not even exist. This 
is true even if we restrict our attention, in defining the master 
sequence, to conserved DNA, i.e. the 5% of the human genome that 
is known to be coding and essential to cell function (see again Alberts 
et al.34, page 206).
Chromosomal master sequences and aneuploid error 
thresholds
We believe that the inconsistences of the basic quasispecies model, 
when applied to human cells, completely disappear if we replace 
single nucleotide errors with aneuploidy errors. Notably, in all sce-
narios where quasispecies theory could potentially apply, i.e. stem 
and progenitor cells proliferation and cancer cells, aneuploidy rates 
far exceed single nucleotide error rates in frequency and impact on 
the cell. This means the leading cause in the evolution of a popula-
tion will be the aneuploidy error, rather than the single nucleotide 
error, which can be neglected, especially when the mismatch repair 
genes are intact as happens in the overwhelming majority of can-
cers and all healthy stem cells.
We need now to reinterpret the notion of reproduction fidelity of a 
sequence adequately to properly define error thresholds in the pres-
ence of aneuploidy. Since we can neglect nucleotide errors, we 
assume a faithful reproduction of the genetic material when the copy 
number of each chromosome in a sequence (two, for example, in a 
diploid cell) is kept constant during replication, both numerically 
(number of physically distinct whole chromosomes or fragments) 
and structurally (translocations, deletions and amplifications of 
DNA). Although complex aneuploidy landscapes may arise, char-
acterized by concurrent numerical and structural chromosomal 
changes, most of the somatic copy-number alterations (SCNAs) 
excess reproduction rate, with Ek = Ak − Dk and, finally, Wmk is the 
rate of production of type m by erroneous reproduction of type k.
Assuming a steady state in which dx
m
/dt = 0 and neglecting in first 
approximation the contributions Σk≠m Wmk xk(t), it is possible to 
derive a condition that constrains the probability of precise repro-
duction of sequence m:
                                        
σ m mmQ >1,
                         
  (2)
where σ¯
m
 = A
m
/(D
m
 + Ē
k≠m
), with Ē
k≠m
= Σ
k≠m 
Ek xk, is the average supe-
riority of a master sequence associated to a dominant subpopulation 
versus competitor sequences, essentially, σ¯
m
 is an index of relative 
fitness27. If a master sequence has length v
m
, and we denote by q¯ the 
average fidelity of single nucleotide reproduction, then Q
mm
 = q¯vm 
and the error threshold can be written as
                                          
σl 1n m
mv
q≥ − .
                               
(3)
Remarkably, Equation 3 establishes a phase transition on the 
information content; if the error rate of single nucleotide repro-
duction goes above lnσ¯ mv
m
—
 the information contained in the master 
sequence will disintegrate, in the sense that the loss of information 
in the sequence due to reproduction errors will not be compensated 
by a sufficiently high fitness relative to other subpopulations and the 
subpopulation associated to the master sequence will implode27,30.
Limitations of quasispecies theory in eucaryotic cells
In complex organisms, the quasispecies model is potentially 
applicable only in specific scenarios, such as competition among 
embryo stem cells during development, adult stem cells and pro-
genitor cells proliferation, and, crucially, cancer cells, where sub-
populations compete with each other under limited resources and 
changing environment. However, the applicability of the basic 
quasispecies model, originally devised in the setting of virus RNA 
replication, has been put into question as appropriate for eucaryotes 
and specifically for cancer cells. Eucaryotic cells reproduce semi-
conservatively meaning that the parental double strand degenerates 
in the process of generating two daughter double strands, which 
led to Brumer et al.21 to raise the possibility that, for high enough 
replication error rates, the master sequence, seen here as the dou-
ble strand of DNA, would eventually disappear, and they suggested 
more refined quasispecies models that take into consideration this 
phenomenon.
Even more seriously, the applicability of quasispecies theory to 
human cells is put into question by the exceedingly high size of 
the human genome as compared to RNA viruses. In fact, in order 
for the quasispecies not to undergo genetic drift, the neutral space 
around a fitness peak should be sufficiently small to be completely 
explored by the population. The complexity and the inherent muta-
tional and phenotypical robustness of the human genome amplifies 
its neutral space, preventing quasispecies evolution even at higher 
than normal mutation rates, as it is the case in cancer cells31. This 
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Given these caveats regarding distribution of fitness for chromosom-
al master sequences in the presence of aneuploidy and regarding 
sub-population interactions, we reach the conclusion that quasispe-
cies theory is indeed applicable to cancer and stem cells, but only in 
the context of aneuploid chromosomal master sequences, neglect-
ing the underlying nucleotide errors.
We can now replace variables in the error threshold inequality in 
Equation 3 to take into account not only the varivariable length c
m
 
of the chromosomal master sequence associated to all whole and 
fragmented chromosomes, but also the correction to the probability 
Q
mm
 of precise reproduction of a sequence that aneuploidy entails. 
The probability of precise reproduction of a specific sequence of 
chromosomes m can be expressed as Q
mm
 = Ācm
m
, and the aneuploid 
error threshold inequality can be written as σ¯
m
Ācm
m
 > 1, which even-
tually gives us a standard form (formally identical to Equation 3) for 
the aneuploid error threshold inequality:
                                      
1ln
σ m
m
mc
A≥ − ,
                       
(4)
However each term in this equation has drastically different 
orders of magnitudes than the threshold inequality for DNA or RNA 
master sequences. To start with, as already stressed above, the rela-
tive superiority σ¯
m
 will have considerable fluctuations, since the 
chromosomal master sequence is much shorter than a nucleotide 
sequence, and even small variations in copy numbers can effect large 
phenotypical variations.
At the same time, the diversity of subpopulations in primary 
tumors16,47–51 implies that, in a fully developed tumor, different sub-
populations do not have extremely different relative superiority σ¯
m
, 
a scenario that would lead to a single, highly dominant subpopulation. 
It is therefore reasonable to assume at the very most σ¯
m
 ∈ [102, 103], 
for the subpopulations of highest relative superiority. We know 
moreover that highly aneuploid tumors have higher fitness52, so 
larger values of σ¯
m
 are likely to be associated with large values of 
c
m
, up to the order of 10213,39,53,54.
Let E
m
 = 1 – Ā
m
, with E
m
 denoting the aneuploidy error rate, i.e. 
the average probability that there is at least one new aneuploid 
defect for each chromosome or fragment of chromosome during 
cell replication. If we call T(E
m
) the threshold aneuploidy error rate 
above which a chromosomal master sequence is not viable, and if 
we take σ¯
m
 ∈ [102, 103], c
m
 ≈ 102, then Equation 4 gives T(E
m
) ≈ 10–2, 
which is consistent with the estimates of E
m
 for cancer cells, in the 
range [10–3, 10–1]3,55–58. Our argument implies that the more a cell is 
aneuploid, the tighter the error threshold bound is, and that highly 
aneuploid cancer cells, known to be most adaptable5,52,59,60, are 
already working with aneuploid error rates close to the limit of a 
viable quasispecies.
There is some evidence that indeed aneuploidy rates in the tumor 
can affect the prognosis of cancer patients9,61. It is suggested that 
a moderate tumor aneuploidy rate worsens the prognosis, while a 
frequently found in tumor cells involve whole chromosomes or 
whole-arms (25% of the genome), with only 10% of the cancer cell 
genome being affected by focal SCNAs9,38,39.
Therefore, we now make a series of definitions consistent with 
these arguments, whose objective is to change the domain of 
applicability of quasispecies theory, without altering its formal 
mathematical structure:
Chromosomal Master Sequence. A chromosomal master sequence 
is the collection of physically distinct whole and fragmented 
chromosomes in the cell.
Chromosomal Master Sequence Length. The chromosomal master 
sequence length c
m
 of a cell is the sum of the copy numbers of 
each whole or fragmented chromosome in its nucleus.
Aneuploid Fidelity. The aneuploid fidelity Ā
m
 is the average 
probability that each whole or fragmented chromosome is reproduced 
exactly once in cell division, with no gain or loss of sub-chromosomal 
regions.
In this aneuploid scenario, the chromosomal master sequence 
length c
m
 can fluctuate depending on the number of aneuploid cop-
ies of whole chromosomes or fragments, and the underlying nucle-
otide sequence will clearly differ according to which chromosomes 
or individual genes are affected by copy-number alterations in each 
cell. Although tumors vary widely in the number and type of copy 
number changes, most of these comprise low-level alterations and 
only a few genes reach more than 20 copy numbers, mainly due to 
their oncogenic or drugresistance functions16,40–42.
Aneuploid events can cause large phenotypical variations43–46, 
even a single error leading to chromosomal loss or addition can 
have large effects, therefore the fitness distribution around a mas-
ter sequence is expected to display a sharp decay from the master 
sequence peak, in line with the types of fitness distribution known 
to express the error threshold30. At least for cancer cells, sub- 
populations are sharply defined in terms of their aneuploid profile, 
as evinced from single cell analysis works16 commented in the 
Discussion. This is further evidence of the strong concentration of 
fitness distributions around a few chromosomal sequence types.
Mutants of the master sequence, generated by even a single aneuploid 
error, and individual cells belonging to other sub-populations, are 
exceedingly unlikely to be able to mutate into cells expressing the 
master sequence, since any additional (erroneous) chromosome copy 
is subject to a wide variety of further partial deletions/additions, and 
only very few of them would correspond to a return to the master 
sequence configuration. Essentially, we can assume that the contri-
bution of cells belonging to other subpopulation types to the dynam-
ical evolution of the master sequence subpopulation is very small. 
This is exactly the condition that led to the error threshold in the first 
place, since Equation 3 is derived as a limiting stationary behavior 
of an interacting family of subpopulations described by Equation 1, 
where the rate of growth of each of them is weakly affected by the 
cross-mutations derived from the other subpopulations27,30.
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study was that the metastasis proliferated from a single cell derived 
from the aneuploid subpopulation of the primary tumor, since no 
pseudodiploid cancer cells were observed in the metastatic tumor.
Other recent studies on myeloproliferative disorders62 and melanoma54, 
kidney47,48 and pancreas49 tumors or, again, in breast cancer50, ar-
rived at similar conclusions, pointing to a late, metastasis-specif-
ic diversification of primary tumor-derived cells (see Wu et al.63, 
Figure S14, and Clifford64). The presence of aneuploid cells in most 
primary tumors examined in Gerlinger et al.49, is well documented 
by ploidy analysis (see supplementary Figure 10 in their paper) and 
metastases show a marked increase in allelic imbalance as com-
pared to primary tumor regions. The authors conclude that tumor 
heterogeneity is probably driven by aneuploidy and that chromo-
somal aberrations contribute substantially to genetic intratumor 
heterogeneity. Notably, even in an evolutionary context where the 
primary tumor and the metastasis share most of the sequenced 
regions, there is a striking variation in copy number specifically in 
the metastatic counterpart (see ref.54, Figures S5 to S11 in Lengauer 
et al.54). This concept is best exemplified in ref.16, but there, both 
the coarse ploidy distribution analysis and the refined, single cell 
copy number count for primary and metastatic tumors, drive us to 
an additional conclusion: the genetic variability of the aneuploid 
clone in the metastasis is greater than its corresponding variability 
in the primary tumor from which it came. Even if we took into 
account a parallel progression model as opposed to a punctuated or 
linear evolution model51,65, the final result would not change. The 
metastatic population described in Navin et al.16 has diversified 
more than its parental population in the primary tumor, regardless 
of whether the metastasis developed in a later, much shorter time 
than the primary tumor, or whether its origins date back to the first 
stages of primary tumor dissemination. This higher diversification 
of the metastatic population holds even though the aneuploid cells’ 
compartment in the primary tumor does not represent a minority of 
the population, and has expanded considerably at some point during 
the tumor evolution history.
To justify our claim of adaptive aneuploidy, we note that in Figure 4 
of Navin et al.16 the Euclidean distances in the neighbor-joining 
tree for the aneuploid cells from the metastatic tumor showed much 
greater variability than the Euclidean distances for the correspond-
ing aneuploid cells in the primary tumor. We note that these dis-
tances were calculated with respect to a common root profile, and 
that mutual distances among individual profiles are likely to be ever 
greater. Granted that this study dealt with very small sample popu-
lations, a closer inspection and analysis of the tightness of the vari-
ance of Euclidean distances in the primary tumor subpopulation, 
as opposed to the variance of Euclidean distances of the metastatic 
tumor subpopulation, would almost certainly reveal a statistically 
significant discrimination of the two. Indeed, distances inferred from 
their Figure 4 of ref.16 using a Levene test for equality of variance66 
suggest a low probability that the underlying distributions of 
Euclidean distances for metastatic aneuploid cells and for primary 
aneuploid cells have the same variance (p-value ≈ 0.01).
Note, crucially, that even if we assume high experimental noise in 
the data, such noise would affect equally both Euclidean distributions 
very high aneuploidy rate is associated with improved patient out-
comes9, consistent with the quasispecies and error threshold catas-
trophe approach.
Discussion
We would like to revisit and comment upon some specific experi-
mental evidence for our proposal of a self-regulated aneuploidy rate 
in cancer cells, focusing on several measures of aneuploidy rate, 
and showing how the variability observed in tumor subpopulations 
subject to distinct micro-environments can be given a far-reaching 
interpretation. Our analysis is phenomenological, meaning that we 
explain and reinterpret existing experimental work, showing how 
the inner logic of our argument can severely constraint the causes 
and interpretation of the data we review. We chose to first perform 
an in-depth analysis of a single recent study16, so that the flow of 
our discourse is unified and made coherent by constant reference to 
the same context. At the same time, we support our arguments with 
related experimental works, when appropriate.
The in-depth analysis and commentary of the literature that we per-
form here is meant to show that there is rigorous, logically compelling, 
and experimentally testable biological evidence for the usefulness of 
an aneuploid quasispecies theory. Indeed, we argue that it is pos-
sible to envision a precise, and functionally in-built mechanism 
of self-regulation for aneuploidy rates in normal and cancer stem 
cells. The evolutionary role and the structure of this self-regulation 
mechanism could be studied and conceptualized within the frame-
work we developed for aneuploid quasispecies. At the same time, 
any experimental validation of aneuploid quasispecies predictions 
on threshold aneuploidy error rates, would be essentially related to 
the presence of this self-regulatory mechanism.
Evidence for self-regulation of aneuploidy rates in cancer cells
The main focus and objective of Navin et al.16 was to show that 
metastatic tumors are likely to be the product of single clones pro-
liferating from the primary tumor by observing the microvariation 
of the integer copy number of consensus sequences in individual 
tumor cells through single-cell sequencing. A coarse ploidy distri-
bution of a large number of cells from a breast tumor and one of its 
metastasis was plotted in Navin et al.16 (Figure 3a-b in that paper) 
as an histogram with respect to the total DNA content. These ploidy 
distributions showed, for both primary and metastatic tumors, two 
peaks, one around twice and another at four times the total amount 
of DNA. This double peaked distribution is accounted by the pres-
ence of roughly 50% of normal diploid cells in each tumor tissue 
sample. Importantly, whereas in the primary tumor a significant 
fraction of the gated normal cells was pseudodiploid, in the paired 
metastasis the normal population was likely to derive from the stro-
mal content of the tissue (see ref.16, Figure 4 in their paper). 
Navin et al.16 performed very refined measurements of copy number 
profiles, across all chromosomes, from a small subset of cells (hun-
dreds) in sections of primary and metastatic tumors and generated 
a neighbor-joining tree of these profiles. This analysis showed that 
metastatic and primary aneuploid cells were closely related in the 
neighbor-joining tree derived from the clustering, and yet they pro-
duced clearly distinct subclusters. The conclusion of this single cell 
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A diversification factor
The Discussion, up to now, centered on the inference, from some 
experimental results of ref.16 and other published supportive infor-
mation48,54,63, that metastatic cancer cells have higher aneuploidy 
rates than the corresponding original subpopulation of the primary 
tumor. We concluded that this differential could only be explained 
by assuming an adaptive, self-regulatory cellular response sensitive 
to changes in the environment. As much as tumor populations 
undergo extensive evolution during their development, it seems 
highly unlikely that such a refined property could arise by chance 
only in the specific population studied in Navin et al.16, without a 
preexisting dormant ability to self-regulation.
Indeed, high levels of aneuploidy are associated with increased 
adaptability in plants and yeast68,69, and a certain rate of aneuploidy, 
leading to precise percentages of mosaic aneuploidy, is common in 
several mammals’ embryos (see van Soom & Boerjan70 chapter 10), 
including humans71,72. Similarly, it is speculated that the significant 
mosaic aneuploidy in adult human organs such as the liver and 
brain is instrumental to an increased plasticity and adaptability of 
such organs73,74. Lang et al.75 raise the possibility that the extensive 
aneuploidy in the embryo may transfer into similarly widespread 
copy number variations in all human tissues.
Observable levels of aneuploidy have been found in adult cells76, 
and while this widespread aneuploidy could already originate dur-
ing embryo development75, adult, non-transformed stem cells con-
tinue to have distinct levels of aneuploidy rates according to their 
type. For example, mesenchymal stem cells are likely to have very 
low aneuploidy rates77, while hepatocytes together with small intes-
tine and pancreas cells display within-tissue extensive copy number 
variation (CNV)78,79.
These strikingly different aneuploidy rates among embryo stem 
cells and adult stem cells, raise the possibility that the finely tuned, 
and distinct, high aneuploidy rates observed in embryos and adult 
tissues are regulated by some mechanism specific to stem cells, 
rather than being a simple byproduct of aberrant or sustained cell 
division. This is a simple, fundamental observation, and yet one 
that is rarely emphasized in the literature. We formalize its essence 
in a proposition:
Differentially Expressed Aneuploidy in Stem Cells. Embryo and 
adult stem cells display finely tuned, and distinct, aneuploidy rates, 
unrelated to the replication rates of the stem cells themselves.
And we refer to Section 2 of our preprint ‘Stem-like Adaptive 
Aneuploidy and Cancer Quasispecies’ (available at arxiv.org/
pdf/1303.6374.pdf) for a much more thorough review of literature 
supporting the idea of a differentially expressed aneuploidy in stem cells.
Since many types of cancers partially inherit the hierarchical struc-
ture of the tissues they have derived from and are assumed to be 
propagated by stemlike tumor cells80, it is possible that increased 
aneuploidy rates are used actively, to the population advantage, to 
and the identification of distinct variances for distances of meta-
static aneuploidy cells and primary aneuploidy cells would be even 
more unlikely to be observed by chance.
The hypothesis of a larger variability of the copy number profiles of 
the metastatic subpopulation is also supported by a closer inspec-
tion of the tails of the ploidy distributions of primary and meta-
static tumor populations analyzed in Navin et al.16. The right-hand 
sides of the tetraploid peaks for the metastatic tumor have distinctly 
thicker and longer tails than the corresponding tetraploid peaks in 
the primary tumor, suggesting greater variability of aneuploidy in 
the former. Other works point to a similar conclusion. For exam-
ple, it has been shown recently that, although sharing most of the 
examined somatic single-nucleotide variants, in vitro cultured low 
passage melanoma cells have higher copy number variation when 
compared to the parental tumor67.
Ploidy distributions, in their simplicity, offer even more scope for 
interpretation and testing of the hypothesis that cancer cells have 
the ability to self-regulate their aneuploidy rate. Indeed, a single 
cell clone could be capable of generating a diverse metastasis either 
because of inherent chromosomal instability, or because its rate of 
aneuploidy is somehow increased under the stress conditions of a 
new tissue embedding.
Let’s assume first that the single clone from the primary tumor has 
chromosomal instability. The dispersion of metastatic cells should 
not be in any way preferential to such cells (even if their successful 
embedding in a tissue may be), so there will be a, possibly small, 
subpopulation of cells in the primary tumor with similar or higher 
aneuploidy rate than the cell generating the metastasis. This sub-
population of the primary tumor, by its greater aneuploidy rate, 
will be more adaptable and likely self-sustaining, and it should be 
observable as a long tail in the ploidy distribution of the primary 
tumor population. The tail will be much thinner for the primary tumor 
than the metastatic tumor, since high aneuploidy rate cells are only 
a sub-population of the primary tumor. However, no such long and 
thin tail is observed experimentally for the primary tumor in Navin 
et al.16. It is still possible, if highly unlikely, that the metastatic cell 
is an extreme outlier, with no comparable cells left in the primary 
tumor, but then we would see a much more pronounced evolution-
ary difference between primary and metastatic aneuploid popula-
tions than what is observed. This logically implies that the single 
metastatic cell clone was not essentially different from its primary 
population before starting to proliferate in the new environment.
This argument leaves only one other option: some cancer cells are 
capable of altering and self-regulating their aneuploidy rate under 
stress, or under changes in the environment. In conclusion, both 
ploidy distribution analysis and single cell analysis of Navin et al.16 
give strong evidence for the proposition on adaptive aneuploidy in 
cancer cells presented in the Introduction, i.e. that single clone cancer 
cells derived from an aneuploid cancer subpopulation, adapt 
their aneuploid rates in distinct environments, namely primary and 
metastatic microenvironments.
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aneuploidy in (all) stem cells that we argue the following hypoth-
esis is strongly implied:
A Diversification Factor: There exists a cellular mechanism 
that regulates adaptation of aneuploidy rates, active, to different 
degrees and in different modalities, in all embryo, adult and cancer 
stem cells.
Conclusions
While it was not the main objective of this theoretical paper to 
explore the experimental consequences of our hypothesis on adap-
tive aneuploidy and aneuploid quasispecies, we note that all our 
statements are open to, indeed they invite, simple forms of vali-
dation, either through single cell analysis or ploidy distribution 
analysis. Elucidating the mechanisms underlying self-regulation of 
aneuploidy rates in stem cells under specific microenvironmental 
stresses, would provide crucial insight into the developmental and 
evolutionary processes of complex organisms.
Finally, we emphasize that validation of the hypothesis that stem 
cells can adapt their aneuploidy rate through a diversification fac-
tor would have significant therapeutical implications, when special-
ized to cancer stem cells. Indeed, it would provide a biological way, 
mostly inactive or less sensitive in healthy adult cells, to induce an 
aneuploid quasispecies error catastrophe to weaken cancer popula-
tions, a long held hope that may yet prove itself true.
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increase the adaptability of stem or fast-dividing progenitor cells. It 
is worth noting that, to date and to our knowledge, only two stud-
ies assessed the relationship between aneuploidy and cancer stem 
cells (CSCs)81,82. In the first paper, Kusumbe and Bapat evaluated 
the expression of stem-cell markers and the DNA content distribu-
tion of fluorescently labeled ovarian cancer cells after subcutane-
ous injection into immunodeficient mice. The authors found that, 
unlike label-free tumor cells, the label-retaining (quiescent) cells 
displayed stem-cell markers and were embedded with a small frac-
tion of aneuploid cells. Treatment with chemotherapy increased the 
percentage of quiescent cells in the overall population and selec-
tively stimulated the proliferation of the aneuploid fraction, which 
retained stem-like properties upon removal of the drug81. A second 
study by Fujimori et al., reveals again that stressful conditions 
favor the emergence of CSC-like clones from differentiating embryo 
stem cells in in vitro culture82.
And this brings us to the proposition we stated in the introduction 
on adaptive aneuploidy in cancer cells: in light of the refined use of 
aneuploidy in stem cells, self-regulation of aneuploidy as argued in 
this Discussion could be a reactivation, in cancer stem cells, of a 
preexisting cellular mechanism common to embryo and adult stem 
cells - a diversification factor. Note that the proposition on differ-
entially expressed levels of aneuploidy in normal stem cells is not 
compatible with a random, self-catalytic increment of aneuploidy 
first suggested in Rasnick & Duesby45, since otherwise we would 
not be able to observe consistently similar levels of aneuploidy 
within each stem cell type, and among different individuals. Moreo-
ver, we would see a correlation between fast replicating stem cells 
and levels of aneuploidy in the corresponding tissue. This is not 
necessarily the case. For example the percentage of cells undergo-
ing DNA replication in solid tumors, which are mostly aneuploid, 
varies between 2% to 8%, whereas a normal renewing epithe-
lium such as the intestine exhibits a DNA replication index of 
approximately 16%83.
A random progression of aneuploidy would display much more 
pronounced variability within each stem cell class, while the spread 
of aneuploidy would be similar in all stem cell classes, and not 
differentially expressed in each of them. Note that the theory of 
a self-catalytic origin of aneuploidy in principle could be made 
consistent with the proposition on adaptive aneuploidy in cancer. 
It is only by taking together the proposition on adaptive aneuploidy 
in cancer (stem) cells, and the proposition on differentially expressed 
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The authors emphasize in their introduction to the present paper that: “The theoretical frame to
”, however, they introduce a change inunderstand such self-regulation resides with quasispecies theory
its definition or the meaning of its objects. In particular, they propose a novel definition of the
chromosomal master sequence. Finally, they discuss the potential origin of this self-regulatory ability in
the wider context of developmental and comparative biology with emphasis on a putative “diversification
factor”, defined as a cellular mechanism regulating the adaptation of aneuploidy rates, which is active in
all embryonic and adult cells, as well as cancer stem cells. Furthermore, they refer to literature asserting
that single clone cancer cells derived from an aneuploid cancer subpopulation, are capable of adapting
their aneuploidy rate, and they display distinct aneuploid rates in distinct environments, namely primary
and metastatic microenvironments.
 
This literature survey indicates that embryonic and adult stem cells display finely tuned, and distinct,
aneuploidy rates, which are unrelated to the replication rates of the stem cells in question. Since many
types of cancer cells partially inherit the hierarchical structure of the tissues from which they emanate, and
are hypothesized to develop from stem like tumor cells, it seems highly probable that increased
aneuploidy rates are used as an advantage to a given cell population, e.g. to increase the adaptability of
stem or fast-dividing progenitor cells.
 
In this article the authors introduce the concept of a “diversification factor”, which is probably the key issue
of the article. This factor may as well be extended to a cluster of “impacting signals”, which may fit the
modern definition of epigenetics, encompassing signals defined as “epigenators”, “initiators” and
“maintainers”, of which transcription factors (TFs), microRNAs and histone modifying enzymes (like
histone deacetylases = HDACS) are known to play important parts, since they constitute a strongly
interwoven network with feed-forward- and feed-back regulatory loops.
 
This network is under the influence of environmental/positional “factors” (epigenators, e.g. surface
molecules, mechanical stimulation, environmental chemicals and others) recognized by the
“initiators/maintainers” (e.g. TFs and microRNAs), and most importantly, this regulatory web is common to
embryonic cells, stem cells, cancer stem cells, and adult (i.e. differentiated) cells. It is therefore highly
probable that the degree of aneuploidy of cancer cells is highly dependent on environmental phenomena,
and not solely on intrinsic or “inherited” traits localized within the cancerous cells themselves.
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and not solely on intrinsic or “inherited” traits localized within the cancerous cells themselves.
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